BEIJING, March 27 (Xinhua) -- Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback